Search

Your search keyword '"Justine M. Kahn"' showing total 2 results
Start Over Author "Justine M. Kahn" Journal cancer medicine
2 results on '"Justine M. Kahn"'

1. Patterns of National Cancer Institute‐Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults

Author

Michael Roth, Melissa Beauchemin, Justine M. Kahn, and Archie Bleyer

Subjects
adolescents and young adults, Black or African American, cancer treatment trials, disparities, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Both adolescent and young adult (AYA) and Black or African American (hereafter referred to as Black) cancer patients are historically under‐enrolled in cancer treatment trials (CTT). The purpose of this study was to quantify enrollment of Black AYAs in National Cancer Institute (NCI)‐sponsored CTTs overall and by age, sex, and cancer diagnosis during 2000–2015. Methods Utilizing data from NCI’s Cancer Therapy Evaluation Program and the Surveillance, Epidemiology and End Results (SEER) Program, we assessed CTT enrollment in Black patients with cancer and measured changes in enrollment over time between the study periods 2000–2007 and 2008–2015. Enrollment patterns were compared across age groups (≤14 years [y], 15–19y, 20–29y, 30–39y and 40+ years), sex, and cancer diagnosis. Results From 2000 through 2015,

Published
2021
Full Text
View/download PDF

2. Patterns of National Cancer Institute‐Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults

Author

Justine M. Kahn, Melissa Beauchemin, Archie Bleyer, and Michael Roth

Subjects
Gerontology, End results, Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, Young Adult, Sex Factors, Age groups, Cancer Therapy Evaluation Program, Neoplasms, Epidemiology, Medicine, Humans, Radiology, Nuclear Medicine and imaging, Young adult, Healthcare Disparities, cancer treatment trials, Research Articles, RC254-282, disparities, Clinical Trials as Topic, business.industry, Patient Selection, Age Factors, Cancer, Clinical Cancer Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Targeted interventions, medicine.disease, National Cancer Institute (U.S.), United States, humanities, Clinical trial, Black or African American, Oncology, Female, business, adolescents and young adults, Research Article
Abstract

Background Both adolescent and young adult (AYA) and Black or African American (hereafter referred to as Black) cancer patients are historically under‐enrolled in cancer treatment trials (CTT). The purpose of this study was to quantify enrollment of Black AYAs in National Cancer Institute (NCI)‐sponsored CTTs overall and by age, sex, and cancer diagnosis during 2000–2015. Methods Utilizing data from NCI’s Cancer Therapy Evaluation Program and the Surveillance, Epidemiology and End Results (SEER) Program, we assessed CTT enrollment in Black patients with cancer and measured changes in enrollment over time between the study periods 2000–2007 and 2008–2015. Enrollment patterns were compared across age groups (≤14 years [y], 15–19y, 20–29y, 30–39y and 40+ years), sex, and cancer diagnosis. Results From 2000 through 2015, This study documents that compared with Black children, Black adolescent and young adult (AYA) patients were less likely to enroll in NCI‐sponsored CTTs from 2000 to 2015. Black AYA male enrollment decreased with increasing age, highlighting disparities among this specific population in CTT enrollment.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results